Translating stem cell research to cardiac disease therapies: Pitfalls and prospects for improvement three sections with opinions separately and independently expressed by

Journal of the American College of Cardiology

Volumn 64, Issue 9, 2014, Pages 922-937

  Rosen, Michael R ^a   Myerburg, Robert J ^b   Francis, Darrel P ^c   Cole, Graham D ^c   Marbán, Eduardo ^d  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

cell based therapy; heart diseases; research design; stem cell research; stem cell transplantation; tissue based therapy

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; BONE MARROW DERIVED MONONUCLEAR CELL; CARDIAC STEM CELL; CARDIOSPHERE DERIVED CELL; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; HEART ARRHYTHMIA; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL; MORBIDITY; MORTALITY; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEM CELL RESEARCH;

CELL-BASED THERAPY; HEART DISEASES; RESEARCH DESIGN; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; TISSUE-BASED THERAPY;

ANIMALS; BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; CLINICAL TRIALS AS TOPIC; EMBRYONIC STEM CELLS; GUIDELINES AS TOPIC; HUMANS; MYOCARDIUM; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 84907305378     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.06.1175     Document Type: Review

References (137)

1. T. Reffelmann, S. Konemann, and R.A. Kloner Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy J Am Coll Cardiol 53 2009 305 308
2. Morbidity and Mortality: 2000 Chartbook on Cardiovascular, Lung, and Blood Diseases 2000 National Institutes of Health: NHLBI, Heart, Lung, and Blood Institute Bethesda, MD
3. E. Braunwald Shattuck lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities N Engl J Med 337 1997 1360 1369
4. E. Puymirat, T. Simon, and P.G. Steg et al. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction JAMA 308 2012 998 1006
5. A.S. Go, D. Mozaffarian, and V.L. Roger et al. Heart disease and stroke statistics - 2013 update: a report from the American Heart Association Circulation 127 2013 e6 e245
6. N. Wade Tracking the uncertain science of growing heart cells March 14, 2005 The New York Times Available at: http://www.nytimes.com/2005/03/14/health/ 14heart.html?-r=0 Accessed January 22, 2014
7. U.S. Department of Health & Human Services. NIH stem cell information. Available at: http://stemcells.nih.gov/Pages/Default.aspx. Accessed June 29, 2014.
8. K.S. Telukuntla, V.Y. Suncion, and I.H. Schulman et al. The advancing field of cell-based therapy: insights and lessons from clinical trials J Am Heart Assoc 2 2013 e000338
9. M. Schoenfeld, W.H. Frishman, and A. Leri et al. The existence of myocardial repair: mechanistic insights and enhancements Cardiol Rev 21 2013 111 120
10. T.L. Rasmussen, G. Raveendran, and J. Zhang et al. Getting to the heart of myocardial stem cells and cell therapy Circulation 123 2011 1771 1779
11. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
12. A. Novak, R. Shtrichman, and I. Germanguz et al. Enhanced reprogramming and cardiac differentiation of human keratinocytes derived from plucked hair follicles, using a single excisable lentivirus Cell Reprogram 12 2010 665 678
13. T. Zhou, C. Benda, and S. Dunzinger et al. Generation of human induced pluripotent stem cells from urine samples Nat Protoc 7 2012 2080 2089
14. K. Takahashi, and S. Yamanaka Induced pluripotent stem cells in medicine and biology Development 140 2013 2457 2461
15. K. Schenke-Layland, and W.R. MacLellan Induced pluripotent stem cells: it's like deja vu all over again Circulation 120 2009 1462 1464
16. S.D. Schwartz, J.P. Hubschman, and G. Heilwell et al. Embryonic stem cell trials for macular degeneration: a preliminary report Lancet 379 2012 713 720
17. D. Castelvecchi Japan to start stem-cell study on humans July 30, 2013 Nature News Blog Available at: http://blogs.nature.com/news/2013/07/japan-to- start-stem-cell-study-on-humans.html Accessed September 15, 2013
18. C. Terrenoire, K. Wang, and K.W. Tung et al. Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics J Gen Physiol 141 2013 61 72
19. R.R. Makkar, R.R. Smith, and K. Cheng et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial Lancet 379 2012 895 904
20. A.R. Chugh, G.M. Beache, and J.H. Loughran et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance Circulation 126 2012 S54 64
21. P. Menasche, O. Alfieri, and S. Janssens et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation Circulation 117 2008 1189 1200
22. A.N. Nowbar, M. Mielewczik, and M. Karavassilis et al. Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis BMJ 348 2014 g2688
23. J. Kajstura, M. Rota, and D. Cappetta et al. Cardiomyogenesis in the aging and failing human heart Circulation 126 2012 1869 1881
24. C.Y. Johnson Data faulted; Brigham study on heart cells is withdrawn April 9, 2014 Boston Globe, Health and Wellness
25. C.Y. Johnson Brigham researcher facing new questions after retraction April 11, 2014 Boston Globe, Health and Wellness
26. The Lancet Editors Expression of concern: the SCIPIO trial Lancet 383 2014 1279
27. J. Bartunek, W. Sherman, and M. Vanderheyden et al. Delivery of biologics in cardiovascular regenerative medicine Clin Pharmacol Ther 85 2009 548 552
28. B. Vrtovec, G. Poglajen, and L. Lezaic et al. Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy Circulation 128 2013 S42 S49
29. V.Y. Suncion, E. Ghersin, and J.E. Fishman et al. Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally? An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial Circ Res 114 2014 1292 1301
30. V. Karantalis, D.L. DiFede, and G. Gerstenblith et al. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial Circ Res 114 2014 1302 1310
31. A.R. Chugh, and J.A. Lima PROMETHEUS and POSEIDON: harnessing the power of advanced cardiac imaging Circ Res 114 2014 1222 1224
32. F.S. Loffredo, M.L. Steinhauser, and J. Gannon et al. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair Cell Stem Cell 8 2011 389 398
33. P. Bianco, R. Barker, and O. Brustle et al. Regulation of stem cell therapies under attack in Europe: for whom the bell tolls EMBO J 32 2013 1489 1495
34. C.E. Murry, M.H. Soonpaa, and H. Reinecke et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts Nature 428 2004 664 668
35. L.B. Balsam, A.J. Wagers, and J.L. Christensen et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium Nature 428 2004 668 673
36. C. Mummery, and M.J. Goumans Shedding new light on the mechanism underlying stem cell therapy for the heart Mol Ther 19 2011 1186 1188
37. P.C. Hsieh, V.F. Segers, and M.E. Davis et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury Nat Med 13 2007 970 974
38. L. Timmers, S.K. Lim, and I.E. Hoefer et al. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction Stem Cell Res 6 2011 206 214
39. M. Mirotsou, T.M. Jayawardena, and J. Schmeckpeper et al. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart J Mol Cell Cardiol 50 2011 280 289
40. M.Z. Ratajczak, M. Kucia, and T. Jadczyk et al. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia 26 2012 1166 1173
41. K.S. Schweitzer, B.H. Johnstone, and J. Garrison et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking Am J Respir Critical Care Medi 183 2011 215 225
42. S. Gatti, S. Bruno, and M.C. Deregibus et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury Nephrol Dial Transplant 26 2011 1474 1483
43. M. Gnecchi, P. Danieli, and E. Cervio Mesenchymal stem cell therapy for heart disease Vascul Pharmacol 57 2012 48 55
44. N. Smart, and P.R. Riley The stem cell movement Circ Res 102 2008 1155 1168
45. B.A. Scruggs, J.A. Semon, and X. Zhang et al. Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model Stem Cells Transl Med 2 2013 797 807
46. E.C. Perin, J.T. Willerson, and C.J. Pepine et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial JAMA 307 2012 1717 1726
47. M.C. Capogrossi Cardiac stem cells fail with aging: a new mechanism for the age-dependent decline in cardiac function Circ Res 94 2004 411 413
48. D. Cesselli, A.P. Beltrami, and F. D'Aurizio et al. Effects of age and heart failure on human cardiac stem cell function Am J Pathol 179 2011 349 366
49. J.M. Zimmet, and J.M. Hare Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy Basic Res Cardiol 100 2005 471 481
50. Fortino A. The purpose of higher education: to create prepared minds. Available at: http://www.evolllution.com/opinions/the-purpose-of-higher- education-to-create-prepared-minds/. Accessed June 29, 2014.
51. M.R. Rosen Are stem cells drugs? The regulation of stem cell research and development Circulation 114 2006 1992 2000
52. H. Shen Stricter standards sought to curb stem-cell confusion Nature 499 2013 389
53. M.R. Rosen The math of Sisyphus: the conundrum of stem cell administration for myocardial infarction and myocardial failure Can J Cardiol 2013 Nov 27 [E-pub ahead of print]
54. K. Malliaras, R.R. Makkar, and R.R. Smith et al. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction) J Am Coll Cardiol 63 2014 110 122
55. Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration (ALLSTAR). Available at: http://clinicaltrials.gov/show/NCT01458405. Accessed June 29, 2014.
56. R. Bolli, A.R. Chugh, and D. D'Amario et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial Lancet 378 2011 1847 1857
57. L.M. Friedman, C.D. Furberg, and D.L. DeMets Fundamentals of Clinical Trials 2010 Springer New York
58. American Heart Association. 2012 top 10 advances in heart disease and stroke research. Available at: http://newsroom.heart.org/news/2012-top-10- advances-in-heart-241901. Accessed June 29, 2014.
59. J.P. Ioannidis Contradicted and initially stronger effects in highly cited clinical research JAMA 294 2005 218 228
60. D.L. Bhatt, D.E. Kandzari, and W.W. O'Neill et al. A controlled trial of renal denervation for resistant hypertension N Engl J Med 370 2014 1393 1401
61. F.H. Messerli, and S. Bangalore Renal denervation for resistant hypertension? N Engl J Med 370 2014 1454 1457
62. M.J. Shun-Shin, J.P. Howard, and D.P. Francis Removing the hype from hypertension BMJ 348 2014 g1937
63. D.P. Francis, M. Mielewczik, and D. Zargaran et al. Autologous bone marrow-derived stem cell therapy in heart disease: discrepancies and contradictions Int J Cardiol 168 2013 3381 3403
64. J. Bartunek, A. Behfar, and D. Dolatabadi et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics J Am Coll Cardiol 61 2013 2329 2338
65. M. Mielewczik, G.D. Cole, and A.N. Nowbar et al. The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE) J Am Coll Cardiol 62 2013 2453
66. J. Bartunek, A. Behfar, and D. Dolatabadi et al. Reply: The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE) J Am Coll Cardiol 62 2013 2454 2456
67. A.N. DeMaria When abstracts conflict with published papers J Am Coll Cardiol 62 2013 1489 1490
68. D.M. Hartung, D.A. Zarin, and J.M. Guise et al. Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications Ann Intern Med 160 2014 477 483
69. J. LeLorier, G. Gregoire, and A. Benhaddad et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials N Engl J Med 337 1997 536 542
70. V. Jeevanantham, M. Butler, and A. Saad et al. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis Circulation 126 2012 551 568
71. R. de Jong, J.H. Houtgraaf, and S. Samiei et al. Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials Circ Cardiovasc Int 7 2014 156 167
72. R.J. Myerburg, V. Reddy, and A. Castellanos Indications for implantable cardioverter-defibrillators based on evidence and judgment J Am Coll Cardiol 54 2009 747 763
73. G.P. Smith Setting limits: medical technology and the law Sydney Law Rev 23 2001 283 296
74. P. Aries Western Attitudes Toward Death 1974 Johns Hopkins University Press Baltimore, MD
75. H.C. Ott, T.S. Matthiesen, and S.K. Goh et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart Nat Med 14 2008 213 221
76. T.Y. Lu, B. Lin, and J. Kim et al. Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells Nat Commun 4 2013 2307
77. K. Le Blanc, L. Tammik, and B. Sundberg et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex Scand J Immunol 57 2003 11 20
78. W.T. Tse, J.D. Pendleton, and W.M. Beyer et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation Transplantation 75 2003 389 397
79. R.J. Myerburg, H. Halperin, and D.A. Egan et al. Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: report from a National Heart, Lung, and Blood Institute workshop Circulation 128 2013 2532 2541
80. International Society for Stem Cell Research. Guidelines for the clinical translation of stem cells. Available at: http://www.isscr.org/home/ publications/ClinTransGuide. Accessed June 29, 2014.
81. J.M. Hare, R. Bolli, and J.P. Cooke et al. Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN) Circulation 127 2013 1630 1635
82. Foundation for the National Institutes of Health. The Biomarkers Consortium launches I-Spy 2 breast cancer clinical trial. March 17, 2010. Available at: http://www.fnih.org/work/key-initiatives-0/i-spy-2-investigation- serial-studies-predict-your-therapeutic-response. Accessed June 29, 2014.
83. I-SPY 2 trial. Available at: http://ispy2.org/i-spy-team/organization- governance. Accessed July 23, 2014.
84. A. Abbott Stem-cell ruling riles researchers Nature 495 2013 418 419
85. International Society for Stem Cell Research. ISSCR voices concern as Italian government authorizes unproven stem cell therapy. April 9, 2013. Available at: http://www.isscr.org/home/about-us/news-press-releases/2013/2013/ 04/10/isscr-voices-concern-as-italian-government-authorizes-unproven-stem-cell- therapy. Accessed June 29, 2013.
86. A. Abbott Italian stem-cell trial based on flawed data July 2, 2013 Nature News Available at: http://www.nature.com/news/italian-stem-cell-trial- based-on-flawed-data-1.13329 Accessed June 29, 2014
87. E.D. Thomas, H.L. Lochte Jr., and W.C. Lu et al. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy N Engl J Med 257 1957 491 496
88. B. Ginzburg The Fall of the Faculty 2011 Oxford University Press New York
89. D. Bok Universities in the Marketplace: the Commercialization of Higher Education 2003 Princeton University Press Princeton
90. Quigg C. A Scientist's Responsibilities. Closing remarks at the Illinois Mathematics & Science Academy Dialogue: Ethical Awareness for Tomorrow's Leaders. Adler Planetarium, Chicago. April 3, 2003. Available at: http://lutece.fnal.gov/Talks/IMSAethics.html. Accessed June 29, 2014.
91. R.J. Myerburg, D.W. Feigal Jr., and B.D. Lindsay Life-threatening malfunction of implantable cardiac devices N Engl J Med 354 2006 2309 2311
92. BAMI. The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on allcause mortality in acute myocardial infarction. Available at: http://www.bami-fp7.eu. Accessed January 22, 2014.
93. U.I. Sinclair Candidate for Governor: and How I Got Licked New edition 1995 University of California Press Oakland, CA
94. V. Kutyifa, A. Kloppe, and W. Zareba et al. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) J Am Coll Cardiol 61 2013 936 944
95. S.D. Solomon, N. Anavekar, and H. Skali et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients Circulation 112 2005 3738 3744
96. C.E. Raphael, A. Kyriacou, and S. Jones et al. Multinational evaluation of the interpretability of the iterative method of optimisation of AV delay for CRT Int J Cardiol 168 2013 407 413
97. M.J. Shun-Shin, and D.P. Francis Why even more clinical research studies may be false: effect of asymmetrical handling of clinically unexpected values PLoS One 8 2013 e65323
98. J.P. Howard, G.D. Cole, and H. Sievert et al. Unintentional overestimation of an expected antihypertensive effect in drug and device trials: mechanisms and solutions Int J Cardiol 172 2014 29 35
99. S. Bouri, Z.I. Whinnett, and G.D. Cole et al. Definitions of outcome, response and effect in imaging research to avoid confusion J Am Coll Cardiol Img 7 2014 104 106
100. Francis DP. Debate: sympathetic denervation - the case against-Darrel Francis. 2013. Available at: https://www.youtube.com/watch?v=kTtK0FJJ1W4. Accessed June 29, 2014.
101. J.P. Howard, A.N. Nowbar, and D.P. Francis Size of blood pressure reduction from renal denervation: insights from meta-analysis of antihypertensive drug trials of 4,121 patients with focus on trial design: the CONVERGE report Heart 99 2013 1579 1587
102. T.F. Lüscher, and F. Mahfoud Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level? Eur Heart J 35 2014 1706 1711
103. L. Festinger Cognitive dissonance Sci Am 207 1962 93 102
104. S.M.A. Sohaib, Z. Chen, and Z.I. Whinnett et al. Meta-analysis of symptomatic response attributable to the pacing component of cardiac resynchronisation therapy Eur J Heart Fail 15 2013 1419 1428
105. M.D. Bogaard, M. Meine, and A.E. Tuinenburg et al. Cardiac resynchronization therapy beyond nominal settings: who needs individual programming of the atrioventricular and interventricular delay? Europace 14 2012 1746 1753
106. B. Stegemann, and D.P. Francis Atrioventricular and interventricular delay optimization and response quantification in biventricular pacing: arrival of reliable clinical algorithms and research protocols, and how to distinguish them from unreliable counterparts Europace 14 2012 1679 1683
107. A. Marcus Quickest withdrawal ever? Journal yanks paper alleging 800K deaths from Poldermans affair January 20, 2014 Retraction Watch Available at: http://retractionwatch.com/2014/01/20/quickest-withdrawal-ever-journal-yanks- paper-alleging-800k-deaths-from-poldermans-affair/ Accessed June 29, 2014
108. K. Malliaras, M. Kreke, and E. Marban The stuttering progress of cell therapy for heart disease Clin Pharmacol Ther 90 2011 532 541
109. B.E. Strauer, M. Brehm, and T. Zeus et al. [Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction] Dtsch Med Wochenschr 126 2001 932 938
110. M.S. Parmacek, and J.A. Epstein Pursuing cardiac progenitors: regeneration redux Cell 120 2005 295 298
111. C.E. Murry, H. Reinecke, and L.M. Pabon Regeneration gaps: observations on stem cells and cardiac repair J Am Coll Cardiol 47 2006 1777 1785
112. E. Marban, and K. Malliaras Mixed results for bone marrow-derived cell therapy for ischemic heart disease JAMA 308 2012 2405 2406
113. F.H. Seeger, T. Rasper, and A. Fischer et al. Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair Circ Res 111 2012 854 862
114. E. Marban Breakthroughs in cell therapy for heart disease: focus on cardiosphere-derived cells Mayo Clin Proc 89 2014 850 858
115. H.M. Harcourt The American Heritage Dictionary of the English Language 5th edition 2013 Houghton Mifflin Harcourt Boston, MA
116. S. Janssens, C. Dubois, and J. Bogaert et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial Lancet 367 2006 113 121
117. D.R. Davis, Y. Zhang, and R.R. Smith et al. Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue PLoS One 4 2009 e7195
118. N. Gago-Lopez, O. Awaji, and Y. Zhang et al. THY-1 receptor expression differentiates cardiosphere-derived cells with divergent cardiogenic differentiation potential Stem Cell Reports 2 2014 576 591
119. I. Chimenti, R.R. Smith, and T.S. Li et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice Circ Res 106 2010 971 980
120. K. Malliaras, R.R. Smith, and H. Kanazawa et al. Validation of contrast-enhanced MRI to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction Circulation 128 2013 2764 2775
121. M. Mercola, P. Ruiz-Lozano, and M.D. Schneider Cardiac muscle regeneration: lessons from development Genes Dev 25 2011 299 309
122. K.U. Hong, Q.H. Li, and Y. Guo et al. A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice Basic Res Cardiol 108 2013 346
123. K. Malliaras, T.S. Li, and D. Luthringer et al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells Circulation 125 2012 100 112
124. A.J. Boyle, I.K. McNiece, and J.M. Hare Mesenchymal stem cell therapy for cardiac repair Methods Mol Biol 660 2010 65 84
125. L. Gepstein Derivation and potential applications of human embryonic stem cells Circ Res 91 2002 866 876
126. J.V. Terrovitis, R.R. Smith, and E. Marban Assessment and optimization of cell engraftment after transplantation into the heart Circ Res 106 2010 479 494
127. A.G. Ibrahim, K. Cheng, and E. Marban Exosomes as critical agents of cardiac regeneration triggered by cell therapy Stem Cell Reports 2 2014 606 619
128. K.C. Wollert, and H. Drexler Cell therapy for the treatment of coronary heart disease: a critical appraisal Nat Rev Cardiol 7 2010 204 215
129. K. Malliaras, and E. Marban Moving beyond surrogate endpoints in cell therapy trials for heart disease Stem Cells Transl Med 3 2014 2 6
130. D. Leistner, B. Assmus, and S. Erbs et al. Intracoronary infusion of bone marrow-derived mononuclear cells in acute myocardial infarction: 5 year clinical outcome and MRI data of the randomized, double-blind, placebo-controlled REPAIR-AMI trial Circulation 124 2011
131. S. Zhang, A. Sun, and D. Xu et al. Impact of timing on efficacy and safety of intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials Clin Cardiol 32 2009 458 466
132. S.N. Zhang, A.J. Sun, and J.B. Ge et al. Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials Int J Cardiol 136 2009 178 185
133. V. Schachinger, S. Erbs, and A. Elsasser et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction N Engl J Med 355 2006 1210 1221
134. H.V. Huikuri, K. Kervinen, and M. Niemela et al. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction Eur Heart J 29 2008 2723 2732
135. M. Tendera, W. Wojakowski, and W. Ruzyllo et al. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre myocardial regeneration by intracoronary infusion of selected population of stem cells in acute myocardial infarction (REGENT) trial Eur Heart J 30 2009 1313 1321
136. P.N. Lara, and M.W. Redman The hazards of randomized phase II trials Ann Oncol 23 2012 7 9
137. J.M. Wilson Medicine. A history lesson for stem cells Science 324 2009 727 728